Clinical trials
ReSScue
Aiming to reduce disease-related gastro-intestinal symptoms in systemic sclerosis (SSc) by repeat intestinal infusions of Anaerobic Cultivated Human Intestinal Microbiome (ACHIM); a Phase II, randomized, double-blinded placebo-controlled 20 week multicentre study.
Nor-mILDer
Home based clinical management of Interstitial Lung Disease (ILD) in systemic rheumatic conditions; the Nor-mILDeR randomized strategy trial.
RMD-mILDer
Develop Nor-mILDer to an international multi-centre RCT with Oslo, Zurich and Bucharest as sites. Approximately 311 participants will be screened to include 218 candidates with 109 in each study arm
Nor-SScardioCare
The pilot study- To assess feasibility of home monitoring in n=20 patients with pre-existing SSc-associated pulmonary arterial hypertension (PAH).
CONQUEST
Platform Clinical Study for Conquering Scleroderma: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2b Platform Clinical Study to Evaluate the Safety and Efficacy of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis.
SSc-DAIS
Aiming to refine established imaging modalities in systemic sclerosis and explore novel imaging techniques to improve overall disease activity assessment